Surgical robots market projected to hit $21.7 billion by 2035

Market Research Future projects the global surgical robots market will grow from $8.73 billion in 2025 to $21.70 billion by 2035, driven by reimbursement expansion, minimally invasive surgery demand and AI-enabled system upgrades. The fastest growth is expected in ambulatory centers, portable systems and Asia-Pacific as hospitals shift to lower-cost, higher-throughput robotic care.

Why it matters: - Surgical robots are moving from premium capital purchases to workflow tools tied to reimbursement, procedure volume and hospital throughput. - The market’s growth signals more adoption of robot-assisted surgery in hospitals and ambulatory centers, especially as aging populations raise elective procedure demand. - The shift could reshape purchasing decisions toward compact systems, service contracts and data-driven performance tools.

What happened: - Market Research Future projected the global surgical robots market will rise from USD 8.73 billion in 2025 to USD 21.70 billion by 2035. - The forecast implies a 9.5% compound annual growth rate from 2026 to 2035. - The market is expected to reach USD 9.59 billion in 2026, the first year of the forecast period. - A sample report and customization request are available through Market Research Future's report pages: Request a free sample and Ask for customization.

The details: - Reimbursement expansion is a major growth driver, with 2024 and 2025 CMS outpatient payment reforms adding robot-assisted general surgery codes and lifting facility payment for several high-volume cases by 6% to 11%. - China’s NHSA pricing revisions are said to have cut payback periods from about seven years to under five in tier-1 provincial hospitals. - AI-enabled machine vision, navigation and force feedback are improving precision and narrowing complication margins. - Peer-reviewed evaluations cited in the release found active force feedback can reduce peak tissue-retraction and grasping force by up to 43%. - In 2024, global medtech research and development spending on digital surgery topped USD 4.1 billion, with about one-third directed to vision and autonomy technology stacks. - OECD member-state hip and knee replacement volumes have grown about 4.3% annually since 2021. - Guangdong and Jiangsu provinces approved more than 140 robotic system placements in 2024 under revised pricing schedules.

The details: - Surgical systems led the component mix with 54.1% of revenue in 2025. - Services were the fastest-growing component, at a 10.1% CAGR. - Instruments and accessories held 31.4% of revenue in 2025. - Training accounted for 6.2% of the market in 2025. - Orthopedics was the largest surgical area, with 34.2% of revenue in 2025. - Neurosurgery was the fastest-growing surgical area, at a 9.9% CAGR. - General and laparoscopic surgery held 19.6% of revenue in 2025. - Urological surgery accounted for 15.1% of revenue in 2025. - Cardiovascular surgery held 8.2% of revenue in 2025. - Hospitals remained the largest end user, with 69.1% of revenue in 2025. - Ambulatory surgical centers were the fastest-growing end user, at a 10.5% CAGR. - Other end users, including specialty clinics and academic research centers, were valued at USD 0.83 billion in 2025. - Non-portable systems led product type share at 39.9% in 2025. - Portable and cart-based systems were the fastest-growing product category, at a 10.3% CAGR. - Robotic instruments and accessories were positioned as the recurring-revenue base. - Imaging systems were described as a significant share because of integration with imaging, sensing and navigation workflows.

Between the lines: - The report suggests buyers are prioritizing economics over prestige, with utilization and cost per procedure becoming more important than the number of robotic degrees of freedom. - Service contracts, predictive maintenance and benchmarking data are becoming a meaningful revenue stream for vendors. - The market remains concentrated, but challenger brands are gaining ground as patent expiries and reimbursement changes lower barriers. - The top five suppliers still control about 72% to 78% of global revenue, down from more than 85% five years ago. - Intuitive Surgical retains the largest installed base and an estimated 48% to 54% revenue share.

What's next: - North America is projected to keep the lead in installed base and revenue, while Asia-Pacific is expected to post the fastest growth through 2035. - Growth opportunities are concentrated in ambulatory care, refurbished-system programs in emerging markets and supervised autonomy features. - Continued platform refreshes, especially in force feedback and machine vision, are likely to remain a competitive differentiator. - Johnson & Johnson MedTech started clinical trials for its general surgery platform in January 2025, pointing to a potential commercial entry later in the decade. - Other named competitors include Stryker, Medtronic, Zimmer Biomet, Smith+Nephew, Globus Medical, Siemens Healthineers, CMR Surgical, MicroPort MedBot, Asensus Surgical and Brainlab.

The bottom line: - Surgical robotics is entering a new growth phase built on reimbursement, demographic pressure and lower-cost automation, not just advanced hardware.